XML 58 R49.htm IDEA: XBRL DOCUMENT v3.22.2
Financial Instruments - Derivatives Not Designated as Hedging, Fair Value Table (Details) - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Derivatives Not Designated as Hedging Instruments, Fair Value [Line Items]    
Unrealized Gain On Derivative Contracts $ 900 $ 612
Derivative contracts, at fair value (liability) 822 787
Investment Segment    
Derivatives Not Designated as Hedging Instruments, Fair Value [Line Items]    
Collateral for derivative positions 1,224 1,906
Investment Segment | Not designated as hedging instrument | Other assets [Member]    
Derivatives Not Designated as Hedging Instruments, Fair Value [Line Items]    
Asset derivatives, Gross 1,031 1,143
Derivative, Fair Value, Amount Offset Against Collateral, Net [1] (140) (532)
Unrealized Gain On Derivative Contracts [1] 891 611
Investment Segment | Not designated as hedging instrument | Accrued expenses and other liabilities    
Derivatives Not Designated as Hedging Instruments, Fair Value [Line Items]    
Liability derivatives, Gross 942 1,317
Derivative, Fair Value, Amount Offset Against Collateral, Net [1] (140) (532)
Derivative contracts, at fair value (liability) [1] 802 785
Investment Segment | Not designated as hedging instrument | Equity Contract [Member] | Other assets [Member]    
Derivatives Not Designated as Hedging Instruments, Fair Value [Line Items]    
Asset derivatives, Gross 205 68
Investment Segment | Not designated as hedging instrument | Equity Contract [Member] | Accrued expenses and other liabilities    
Derivatives Not Designated as Hedging Instruments, Fair Value [Line Items]    
Liability derivatives, Gross 942 1,317
Investment Segment | Not designated as hedging instrument | Credit Risk Contract [Member] | Other assets [Member]    
Derivatives Not Designated as Hedging Instruments, Fair Value [Line Items]    
Asset derivatives, Gross $ 826 $ 1,075
[1] Excludes netting of cash collateral received and posted. The total collateral posted at June 30, 2022 and December 31, 2021 was $1,224 million and $1,906 million, respectively, across all counterparties, which are included in cash held at consolidated affiliated partnerships and restricted cash in the condensed consolidated balance sheets.